3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
14
Pain
13
Pain, Postoperative
12
Cancer Pain
10
Agnosia
7
Chronic Pain
6
Colorectal Neoplasms
4
Colonic Neoplasms
4
Breast Neoplasms
4
Neoplasm Metastasis
3
Mucositis
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Supratentorial Neoplasms
2
Pancreatic Neoplasms
2
Pain, Intractable
2
Neoplastic Cells, Circulating
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Inflammation
2
Ileus
2
Hematologic Neoplasms
2
Wounds and Injuries
1
Waldenstrom Macroglobulinemia
1
Vesico-Ureteral Reflux
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Pregabalin
5
Lidocaine
4
Surveys and Questionnaires
3
Bupivacaine
3
ziconotide
2
Transcranial Magnetic Stimulation
2
Oxycodone
2
Gabapentin
2
Capsaicin
2
Amitriptyline
2
onabotulinum toxin A
1
Yoga
1
Vitamin B 6
1
Vitamin B 12
1
Vinorelbine
1
Vincristine
1
Transcutaneous Electric Nerve Stimulation
1
Thalidomide
1
Telmisartan
1
Tapentadol
1
Spinal Cord Stimulation
1
Sodium Chloride
1
Saline Solution
1
Radiofrequency Ablation
1
Plastic Surgery Procedures
1
Paclitaxel
1
Oxaliplatin
1
Morphine
1
Methadone
1
Manipulation, Osteopathic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuralgia
×
Morphine
×
Clear all
NCT01946555
2016-04-14
RER
Mario Negri Institute for Pharmacological Research
Completed
150 enrolled